MIRM: Mirum Pharmaceuticals Inc Company Profile & Statistics

About

Mirum Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's product candidate consists of maralixibat, an investigational oral drug in development for progressive familial intrahepatic cholestasis and Alagille syndrome. Mirum Pharmaceuticals Inc. is based in Foster City, United States.

Info & Links

CEO

Christopher Peetz

Headquarters

950 TOWER LANE, SUITE 1050
FOSTER CITY, CA 94404, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

264

Mirum Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization²

2.05B

Enterprise Value

2.14B

Enterprise Value/EBITDA(ttm)

-30.03

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

6.57

Price to Book(mrq)

8.64

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

72.32%

Operating Margin(ttm)

-31.69%

Profit Margin(ttm)

-33.79%

Return on Equity(ttm)

-41.22%

Return on Invested Capital(ttm)

-18.33%

Return on Assets(ttm)

-14.81%

Income Statement

Revenue(ttm)

307.03M

Revenue Per Share(ttm)

6.40

Gross Profit(ttm)

223.14M

EBITDA(ttm)³

-71.26M

Net Income Available to Common(ttm)

-99.81M

Diluted EPS(ttm)

-2.02

Share Statistics

Beta (5Y Monthly)

0.98

52-Week Change

35.02%

S&P 500 52-Week Change

24.75%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

48.00M

Dividend Yield

0.00%

Float⁴

37.03M

% Held by Insiders

22.87%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

284.44M

Total Cash Per Share(mrq)

5.93

Total Debt(mrq)

307.67M

Total Debt/Equity(mrq)

132.60%

Current Ratio(mrq)

3.34%

Quick Ratio(mrq)

3.15%

Book Value Per Share(mrq)

4.84

Cash Flow

Operating Cash Flow Per Share(ytd)

0.32

Free Cash Flow(ytd)

14.42M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

MIRM

Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals Inc Profile